EditordIn December 2019 a cluster of pneumonia cases of unknown aetiology was identified in Wuhan, China. A novel coronavirus was isolated from lower respiratory tract samples and identified as a specific severe acute respiratory syndrome coronovirus-2 (SARS-CoV-2). 1 An increasing number of patients around the world developed coronavirus disease 2019 (COVID-19), which primarily injures the vascular endothelium, with some developing acute respiratory distress (C-ARDS). CARDS is characterised by active lung inflammation and increases in lung vascular permeability and lung weight, as identified in the postmortem analysis of lung tissue from COVID-19 patients where features of the exudative and proliferative phases of diffuse alveolar disease were seen. However, COVID-19 is also associated with damage to the heart, CNS, kidneys, immune cells, and endothelial cells of arteries and veins. It has been reported that, among hospitalised patients with COVID-19, 60e70% presented with CARDS , and up to 30% required ICU admission with an associated mortality ranging from 26% to 78%. 2,3 A recent report of 24 patients with COVID-19 showed that the average BMI was 33 kg m À2. 4 Increased BMI is associated with an increased risk of developing ARDS with a similar risk of mortality. 5,6 Because of the high frequency of obesity reported among patients admitted in the ICU for CARDS , 7 we aimed to investigate if mechanically ventilated CARDS patients had a higher BMI compared with an historical group of consecutive ARDS patients requiring mechanical ventilation. We conducted a retrospective analysis of 140 consecutive CARDS patients admitted to the